Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 75

1.

NMD inhibition fails to identify tumour suppressor genes in microsatellite stable gastric cancer cell lines.

Buffart TE, Tijssen M, El-Bchiri J, Duval A, van de Wiel MA, Ylstra B, Meijer GA, Carvalho B.

BMC Med Genomics. 2009 Jun 29;2:39. doi: 10.1186/1755-8794-2-39.

3.

Identifying candidate colon cancer tumor suppressor genes using inhibition of nonsense-mediated mRNA decay in colon cancer cells.

Ivanov I, Lo KC, Hawthorn L, Cowell JK, Ionov Y.

Oncogene. 2007 May 3;26(20):2873-84. Epub 2006 Nov 6.

PMID:
17086209
4.

A strategy for disease gene identification through nonsense-mediated mRNA decay inhibition.

Noensie EN, Dietz HC.

Nat Biotechnol. 2001 May;19(5):434-9.

PMID:
11329012
5.

Data integration from two microarray platforms identifies bi-allelic genetic inactivation of RIC8A in a breast cancer cell line.

Muggerud AA, Edgren H, Wolf M, Kleivi K, Dejeux E, Tost J, Sørlie T, Kallioniemi O.

BMC Med Genomics. 2009 May 11;2:26. doi: 10.1186/1755-8794-2-26.

6.

The application of nonsense-mediated mRNA decay inhibition to the identification of breast cancer susceptibility genes.

Johnson JK, Waddell N; kConFab Investigators, Chenevix-Trench G.

BMC Cancer. 2012 Jun 15;12:246. doi: 10.1186/1471-2407-12-246.

7.

Nonsense-mediated mRNA decay impacts MSI-driven carcinogenesis and anti-tumor immunity in colorectal cancers.

El-Bchiri J, Guilloux A, Dartigues P, Loire E, Mercier D, Buhard O, Sobhani I, de la Grange P, Auboeuf D, Praz F, Fléjou JF, Duval A.

PLoS One. 2008 Jul 9;3(7):e2583. doi: 10.1371/journal.pone.0002583.

8.

Nonsense mediated decay resistant mutations are a source of expressed mutant proteins in colon cancer cell lines with microsatellite instability.

Williams DS, Bird MJ, Jorissen RN, Yu YL, Walker F, Zhang HH, Nice EC, Burgess AW.

PLoS One. 2010 Dec 31;5(12):e16012. doi: 10.1371/journal.pone.0016012. Erratum in: PLoS One. 2011;6(1). doi: 10.1371/annotation/53805ecf-7d10-4d99-9cec-f27f5e0d4166. Walker, Franscesa [corrected to Walker, Francesca].

9.

Identification of ARHGEF17, DENND2D, FGFR3, and RB1 mutations in melanoma by inhibition of nonsense-mediated mRNA decay.

Bloethner S, Mould A, Stark M, Hayward NK.

Genes Chromosomes Cancer. 2008 Dec;47(12):1076-85. doi: 10.1002/gcc.20598.

PMID:
18677770
10.

The NMD mRNA surveillance pathway downregulates aberrant E-cadherin transcripts in gastric cancer cells and in CDH1 mutation carriers.

Karam R, Carvalho J, Bruno I, Graziadio C, Senz J, Huntsman D, Carneiro F, Seruca R, Wilkinson MF, Oliveira C.

Oncogene. 2008 Jul 10;27(30):4255-60. doi: 10.1038/onc.2008.62. Epub 2008 Apr 21.

PMID:
18427545
11.

Identification of inactivating mutations in the JAK1, SYNJ2, and CLPTM1 genes in prostate cancer cells using inhibition of nonsense-mediated decay and microarray analysis.

Rossi MR, Hawthorn L, Platt J, Burkhardt T, Cowell JK, Ionov Y.

Cancer Genet Cytogenet. 2005 Sep;161(2):97-103.

PMID:
16102578
12.

UPF1, a conserved nonsense-mediated mRNA decay factor, regulates cyst wall protein transcripts in Giardia lamblia.

Chen YH, Su LH, Huang YC, Wang YT, Kao YY, Sun CH.

PLoS One. 2008;3(10):e3609. doi: 10.1371/journal.pone.0003609. Epub 2008 Oct 31.

13.

Inactivation of RB1 in mantle-cell lymphoma detected by nonsense-mediated mRNA decay pathway inhibition and microarray analysis.

Pinyol M, Bea S, Plà L, Ribrag V, Bosq J, Rosenwald A, Campo E, Jares P.

Blood. 2007 Jun 15;109(12):5422-9. Epub 2007 Mar 1.

14.

Nonsense-mediated decay microarray analysis identifies mutations of EPHB2 in human prostate cancer.

Huusko P, Ponciano-Jackson D, Wolf M, Kiefer JA, Azorsa DO, Tuzmen S, Weaver D, Robbins C, Moses T, Allinen M, Hautaniemi S, Chen Y, Elkahloun A, Basik M, Bova GS, Bubendorf L, Lugli A, Sauter G, Schleutker J, Ozcelik H, Elowe S, Pawson T, Trent JM, Carpten JD, Kallioniemi OP, Mousses S.

Nat Genet. 2004 Sep;36(9):979-83. Epub 2004 Aug 8.

PMID:
15300251
15.

Nonsense-mediated mRNA decay in barley mutants allows the cloning of mutated genes by a microarray approach.

Gadjieva R, Axelsson E, Olsson U, Vallon-Christersson J, Hansson M.

Plant Physiol Biochem. 2004 Jul-Aug;42(7-8):681-5.

PMID:
15331098
16.

Manipulation of nonsense mediated decay identifies gene mutations in colon cancer Cells with microsatellite instability.

Ionov Y, Nowak N, Perucho M, Markowitz S, Cowell JK.

Oncogene. 2004 Jan 22;23(3):639-45.

PMID:
14737099
17.

Identification of candidate tumour suppressor gene loci for Hodgkin and Reed-Sternberg cells by characterisation of homozygous deletions in classical Hodgkin lymphoma cell lines.

Giefing M, Arnemann J, Martin-Subero JI, Nieländer I, Bug S, Hartmann S, Arnold N, Tiacci E, Frank M, Hansmann ML, Küppers R, Siebert R.

Br J Haematol. 2008 Sep;142(6):916-24. doi: 10.1111/j.1365-2141.2008.07262.x. Epub 2008 Jul 30.

PMID:
18671701
18.

Alport syndrome. Molecular genetic aspects.

Hertz JM.

Dan Med Bull. 2009 Aug;56(3):105-52.

PMID:
19728970
19.

Incomplete nonsense-mediated mRNA decay in Giardia lamblia.

Chen YH, Su LH, Sun CH.

Int J Parasitol. 2008 Sep;38(11):1305-17. doi: 10.1016/j.ijpara.2008.02.006. Epub 2008 Mar 21.

PMID:
18430426
20.

Integrated genomic and pharmacological approaches to identify synthetic lethal genes as cancer therapeutic targets.

Mizuarai S, Irie H, Schmatz DM, Kotani H.

Curr Mol Med. 2008 Dec;8(8):774-83. Review.

PMID:
19075675
Items per page

Supplemental Content

Write to the Help Desk